Patent Yard Sign in
Canadian application, no grantCanada

Anti-neoplastic compositions and uses thereof

CA 2362995 A1 · Owner: Gyuris, Jeno · Inventors: Finer, Mitchell; Gyuris, Jeno; Mendez, Michael J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a nucleic acid composition consisting essentially of a first nucleic acid sequence encoding a chimeric CDKi protein and a second nucleic acid sequence encoding an adenovirus E4 protein wherein the first and second , nucleic acid sequences are operably linked to at least one regulatory sequence.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 1, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 1, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 1, 2000
GrantedNo grant recorded
Term endedMarch 1, 2020
Patent numberCA 2362995 A1
Classification (IPC)C12N15/86 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMarch 1, 2000Term endedMarch 1, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.